🛡️

LL-37

Cathelicidin LL-37 · CAP-18 · hCAP18/LL-37

Moderate EvidenceImmune & Inflammation

The only human cathelicidin antimicrobial peptide, with broad-spectrum antimicrobial activity, immunomodulation, and wound-healing properties.

Half-Life

~2-3 hours

4493.3 Da

Amino Acids

37 AA

Evidence

Moderate Evidence

Add to Protocol

Regulatory Status

Research compound. Topical applications in clinical trials.

How it works: Add BAC water to your vial → calculator finds concentration → divides your dose by concentration → shows units to draw on a standard 100-unit insulin syringe. Values are pre-filled from research reference defaults — adjust to match your actual vial.

Vial Size (mg)

BAC Water (mL)

Dose (mcg)

fill level

Draw

units on a 100-unit syringe

= 0.02 mL

Conc.

5000

mcg/mL

Vol/dose

0.02

Doses/vial

inj.

Research reference values only. Confirm all parameters with current literature and your clinician.

Looking for multi-compound protocols?

Browse educational protocol discussions that include LL-37.

Protocol Library

Related Compounds

Thymosin Alpha-1

A 28-amino acid peptide derived from the thymus with potent immunomodulatory effects approved in multiple countries for hepatitis and cancer supportive care.

BPC-157

A 15 amino acid peptide derived from human gastric juice, widely researched for its tissue-healing and cytoprotective properties.

Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.